News for 'drug regulations'

Modi first foreign head to get Bhutan's highest civilian honour

Modi first foreign head to get Bhutan's highest civilian honour

Rediff.com22 Mar 2024

Prime Minister Narendra Modi on Friday received Bhutan's highest civilian award, the 'Order of the Druk Gyalpo', making him the first foreign Head of the Government to receive the honour.

AIIMS chief among volunteers for Covaxin's phase-3 trial

AIIMS chief among volunteers for Covaxin's phase-3 trial

Rediff.com26 Nov 2020

The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS in New Delhi on Thursday, with Dr M V Padma Srivastava, the chief of Neurosciences Centre at the premier institute, and three other volunteers receiving the first dose.

Zydus Cadila proposes Rs 1,900 for 3 jabs of DNA-based vaccine

Zydus Cadila proposes Rs 1,900 for 3 jabs of DNA-based vaccine

Rediff.com3 Oct 2021

With talks underway between the central government and Zydus Cadila over the pricing of the COVID-19 vaccine ZyCov-D, the pharma company is learnt to have proposed a price of Rs 1,900 for its three-dose jab that can be given to those above 12 years of age.

Drug makers charged with overcharging of Rs 2,362 cr

Drug makers charged with overcharging of Rs 2,362 cr

Rediff.com15 Mar 2013

National Pharmaceutical Pricing Authority names Cipla, Dr Reddy's Labs and Ranbaxy among those.

9 drug firms may have to gulp Rs 2.5k-cr pill

9 drug firms may have to gulp Rs 2.5k-cr pill

Rediff.com19 Jul 2013

Face NPPA fine for overcharging on anti-asthma drug

Why replacing branded drugs with generics won't be easy

Why replacing branded drugs with generics won't be easy

Rediff.com25 May 2017

Mandatory prescription of generic names is not a complete solution. Rather, in the absence of a range of approaches, it could mean passing the choice of selecting a drug from a doctor to a pharmacist, says Chandrakant Lahariya.

Centre may not get costly Pfizer vaccine

Centre may not get costly Pfizer vaccine

Rediff.com22 Dec 2020

At $37 per dose, the Pfizer vaccine is much more expensive compared to $3 per dose for the Covishield.

Drug price hike: Govt to take action

Drug price hike: Govt to take action

Rediff.com16 Mar 2007

Pharmaceutical companies which increase prices of their medicines beyond 10 per cent in a year will face regulatory action.

Lupin gets USFDA nod for additonal strengths of cholesterol drug

Lupin gets USFDA nod for additonal strengths of cholesterol drug

Rediff.com22 Oct 2013

The company has received final approval for its supplemental New Drug Application (sNDA) for Antara (Fenofibrate) capsules in 30 mg and 90 mg strengths from the United States Food and Drug Administration (USFDA), Lupin Ltd said in a statement.

NTAGI mulls 'additional' Covid jab for immunocompromised

NTAGI mulls 'additional' Covid jab for immunocompromised

Rediff.com5 Dec 2021

According to officials, an additional dose of vaccine is different from a booster dose.

Electoral Bonds: The Quid Pro Quo Factor

Electoral Bonds: The Quid Pro Quo Factor

Rediff.com3 Apr 2024

Which entrepreneur would willingly part with her or his hard-earned money for grasping, self-serving politicians? asks Debashis Basu.

India will wait for DCGI nod to restart Oxford vaccine trial

India will wait for DCGI nod to restart Oxford vaccine trial

Rediff.com11 Sep 2020

The global trials were halted after a study participant suffered a 'potentially unexplained illness, reports Sohini Das.

Dr Reddy's gets warning from US health regulator

Dr Reddy's gets warning from US health regulator

Rediff.com7 Nov 2015

Dr Reddy's gets warning from US health regulator

Lupin gets USFDA nod to market HIV drug in US

Lupin gets USFDA nod to market HIV drug in US

Rediff.com10 Dec 2013

The company has received final approval from the US Food and Drug Administration for its Abacavir Sulfate Lamivudine, and Zidovudine Tablets, Lupin Ltd said in a statement.

Serum Inst to launch first indigenous vaccine against pneumonia

Serum Inst to launch first indigenous vaccine against pneumonia

Rediff.com24 Dec 2020

According to the sources, the vaccine will be much more affordable than existing ones manufactured by two foreign companies. India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm.

Are You Eligible For A Booster Shot?

Are You Eligible For A Booster Shot?

Rediff.com27 Dec 2021

'Someone may have diabetes, but at what level the disease qualifies as a comorbid condition is something a doctor will decide upon and certify accordingly.'

Govt denies pressuring Covaxin makers for early release of vaccine

Govt denies pressuring Covaxin makers for early release of vaccine

Rediff.com17 Nov 2022

The Union health ministry on Thursday termed as 'misleading' and 'fallacious' media reports which claimed that regulatory approval for COVID-19 vaccine Covaxin was rushed due to political pressure.

1 in 7 Indian drugs revealed as substandard

1 in 7 Indian drugs revealed as substandard

Rediff.com16 Feb 2016

More lucrative routinely prescribed drugs are at higher risk of failing quality standards

Lin hopes drugs-hit Lee returns soon

Lin hopes drugs-hit Lee returns soon

Rediff.com13 Nov 2014

China's badminton superstar Lin Dan said he hopes world number one Lee Chong Wei, who is embroiled in a doping scandal, is able to return to the sport soon, state media reported.

'Government cannot, should not regulate the Internet'

'Government cannot, should not regulate the Internet'

Rediff.com31 Mar 2015

'What the Supreme Court decision does is encourage more and more young Indians to get involved in citizenship and democracy and do so more fearlessly.' 'Obviously, this is not a licence to be rude or go defaming people or be obnoxious online or do illegal activities online.' 'But this is a licence and green light for people to get more involved in the country, its politics and governance, its businesses, and be freely expressing your views on it.'

Pharma regulator fails again

Pharma regulator fails again

Rediff.com23 Dec 2008

The death of a participant in a clinical trial by a Hyderabad-based contract research firm has refocused attention on the practices followed by an industry which is said to have great promise, because it can earn good dollars by leveraging cheap Indian skills.

Nicholas Piramal develops novel anti-cancer drug

Nicholas Piramal develops novel anti-cancer drug

Rediff.com18 Nov 2003

Pharma major Nicholas Piramal India Ltd has claimed to have developed a novel anti-cancer drug to arrest and regulate the multiplication of cancer cells.

After US, Germany bans export of Ranbaxy's Dewas plant drugs

After US, Germany bans export of Ranbaxy's Dewas plant drugs

Rediff.com3 Dec 2014

The company did not comply to the 'good manufacturing practice' norms.

Cap on stent prices brings Chinese maker to India

Cap on stent prices brings Chinese maker to India

Rediff.com28 Feb 2017

MicroPort entered the market on Feb 15 and its stent was used in a Mumbai hospital.

What Makes Malayalam Cinema So Distinctive?

What Makes Malayalam Cinema So Distinctive?

Rediff.com11 Apr 2024

The reasons are too private to be discussed at a round table, listed out during a seminar, or uncovered in an academic course. A proud but insomniac connoisseur murmuring in his sleep may do a better job of explaining the phenomenon than an expert on a podium. Sreehari Nair airs his thoughts.

How safe are cheap medicines made in India?

How safe are cheap medicines made in India?

Rediff.com11 Mar 2016

An International Policy Network report in 2010 found that seven per cent of drugs bought from wholesale traders were substandard, and 3.6 per cent of the drugs from traders contained no active ingredient whatsoever.

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Rediff.com31 Dec 2020

The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.

Health ministry okays HCQ for early course of COVID-19

Health ministry okays HCQ for early course of COVID-19

Rediff.com13 Jun 2020

The health ministry on Saturday recommended the use of antiviral drug remdesivir in moderate stage of COVID-19 while backtracking from its earlier stance on hydroxychloroquine, saying the anti-malarial drug should be used in the early course of the disease and not on critically ill patients.

'BJP Has 6,000 Crores To Spend On Elections'

'BJP Has 6,000 Crores To Spend On Elections'

Rediff.com19 Apr 2024

'Not even a single rupee from the electoral bonds should be allowed to be used in the election.' 'If it is used in the election, it will taint India's electoral process itself.'

Apollo Hospitals launches pilot for Sputnik V vaccine

Apollo Hospitals launches pilot for Sputnik V vaccine

Rediff.com17 May 2021

The first phase of the programme will kick off with vaccinations in Hyderabad on Monday and in Visakhapatnam on Tuesday (May 18) at Apollo facilities.

When Munna Bhai Was In Jail

When Munna Bhai Was In Jail

Rediff.com1 Jan 2024

A day before the event, I learnt from an old Mumbai crime branch informant that a group of gangsters were planning to serve breakfast to the prisoners at Balgandharva Rangmandir prior to the show.

India may take WTO action against EU over drug clinical trials

India may take WTO action against EU over drug clinical trials

Rediff.com15 Apr 2015

GVK Biosciences is the latest Indian firm to come under international scrutiny over quality issues.

'Unprecedented vaccine trial in India'

'Unprecedented vaccine trial in India'

Rediff.com23 Dec 2020

Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.

Why price cap on drugs is counter productive

Why price cap on drugs is counter productive

Rediff.com31 May 2016

To ensure equal access to health care, the government must consider it in a holistic manner and improve all parameters.

Bill on uniform civil code not listed for monsoon session of Parliament

Bill on uniform civil code not listed for monsoon session of Parliament

Rediff.com13 Jul 2023

The government on Thursday listed bills on personal data protection, to amend forest conservation laws and on the contentious ordinance on Delhi services for the monsoon session of Parliament beginning next week.

China rolls out first one-jab COVID-19 vaccine: Report

China rolls out first one-jab COVID-19 vaccine: Report

Rediff.com28 Feb 2021

China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the United States drug regulator on Sunday.

Monsoon session of Parliament begins today, set to be stormy

Monsoon session of Parliament begins today, set to be stormy

Rediff.com20 Jul 2023

Parliamentary Affairs Minister Prahlad Joshi has said that 31 bills will be taken up in the monsoon session. Among these include the Digital Personal Data Protection Bill, 2023.

Vaccine will be available to all

Vaccine will be available to all

Rediff.com17 Dec 2020

The vaccine would be first made available to the vulnerable population and eventually, it would be available in the private market for all.

India lauds Brazil's support for actions to combat terror: Modi

India lauds Brazil's support for actions to combat terror: Modi

Rediff.com17 Oct 2016

Prime Minister Narendra Modi also thanked Brazilian President Michel Temer for "understanding India's aspiration" for membership of the Nuclear Suppliers Group.